Galapagos NV (GLPG) Shareholders Approve All Board Proposals streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Merck today announced it has strengthened its Oncology franchise by regaining exclusive worldwide rights to develop, manufacture, and commercialize anti-programmed death ligand-1 (PD-L1) antibody BAVENCIO® (avelumab) following the termination of their Alliance agreement with Pfizer.
Publication of annual report for financial year 2022Annual Shareholders' Meeting proposed resolutions include re-appointment of Board members and appointment of new statutory auditor Mechelen